Yang Zeyi, Li Pengtao, Wei Junji
Department of Neurosurgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
Mol Psychiatry. 2025 Jul 31. doi: 10.1038/s41380-025-03126-6.
Traumatic brain injury (TBI) is a complex and often-devastating condition. This disease involves damage to cerebral structures: meninges (dura, arachnoid, pia), cerebral cortex, white matter tracts, and deeper structures (basal ganglia, brainstem), along with mechanisms including contusions, hematomas (epidural/subdural), diffuse axonal injury from shear forces, secondary edema compromising blood-brain barrier, and ischemia/hemorrhage caused by vascular disruption. The pathophysiological process of TBI above varies significantly among individuals. However, prevalent TBI treatments still focus on symptomatic management, such as surgical intervention represented by craniotomy, medical management represented by osmotic agents for cerebral edema, supportive care represented by oxygen therapy, and adjuvant therapies represented by hypothermia. Worse still, traditional therapies often yield unfavorable outcomes and indulge the potential onset of long-term neurodegenerative diseases (NDDs). On the other side, Glymphatic System (GS), discovered as a clearance system in the brain, has made tremendous progress over the past decade. Dysfunction of the GS has been implicated in various central nervous system (CNS) diseases including TBI. The discovery of the GS offers new perspectives for the pathophysiological process of TBI, particularly unveiling the truth of the development of diphasic brain edema following TBI. Impressively, with the GS maturing, unprecedented therapeutic strategies ensue. For instance, the GS might explain sleep deprivation after TBI strikes in part and strongly validate the prospect of sleep therapy, then provide insights into the enigma of sleep. Also, nor-adrenergic inhibition facilitates CSF-ISF exchange and glymphatic outflow, significantly attenuating brain edema. AQP4, the guardian and regulator of brain capacity at the end-foot of astrocyte, which can modulate its array and amounts aligning with nor-adrenergic signal, is indispensable in this process. Moreover, neurons have gained prominence in the brain's clearance system. Exploring the relationship between the GS and TBI will likely to blaze the new trail for advancing our understanding of TBI.
创伤性脑损伤(TBI)是一种复杂且往往具有毁灭性的病症。这种疾病涉及脑结构的损伤:脑膜(硬脑膜、蛛网膜、软脑膜)、大脑皮层、白质束以及更深层结构(基底神经节、脑干),其机制包括挫伤、血肿(硬膜外/硬膜下)、剪切力导致的弥漫性轴索损伤、破坏血脑屏障的继发性水肿以及血管破裂引起的缺血/出血。上述TBI的病理生理过程在个体间差异显著。然而,目前普遍的TBI治疗仍侧重于对症处理,如以开颅手术为代表的外科干预、以治疗脑水肿的渗透剂为代表的药物治疗、以氧疗为代表的支持治疗以及以低温疗法为代表的辅助治疗。更糟糕的是,传统疗法往往产生不良后果,并助长了长期神经退行性疾病(NDDs)的潜在发作。另一方面,淋巴系统(GS)作为大脑中的一种清除系统,在过去十年取得了巨大进展。GS功能障碍与包括TBI在内的各种中枢神经系统(CNS)疾病有关。GS的发现为TBI的病理生理过程提供了新的视角,尤其揭示了TBI后双相脑水肿发展的真相。令人印象深刻的是,随着GS的成熟,出现了前所未有的治疗策略。例如,GS可能部分解释了TBI后出现的睡眠剥夺现象,并有力地证实了睡眠治疗的前景,进而为睡眠之谜提供见解。此外,去甲肾上腺素能抑制促进脑脊液 - 细胞间液交换和淋巴系统流出,显著减轻脑水肿。水通道蛋白4(AQP4)是星形胶质细胞终足处脑容量的守护者和调节器,它可以根据去甲肾上腺素能信号调节其排列和数量,在此过程中不可或缺。此外,神经元在大脑清除系统中也日益重要。探索GS与TBI之间的关系可能会为增进我们对TBI的理解开辟新的道路。